The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential.
Open accessAbstract
Diabetes was induced in a normal nonautoimmune rat strain by rendering the animals relatively T cell deficient using a protocol of adult thymectomy and sublethal gamma irradiation. All male rats and 70% of females developed an acute syndrome with severe loss of weight and hyperglycemia. Diabetes in these lymphopoenic rats was associated with extensive insulitis involving CD4+ and CD8+ T cells and macrophages. The CD8+ T cells were essential for the development of diabetes but not insulitis. The autoimmune diabetes and insulitis were completely prevented by the injection of a particular CD4+ T cell subset, isolated from healthy syngeneic donors, of the phenotype CD45RClow T cell receptor alpha/beta+ RT6+ Thy-1- OX-40-. Cells of this protective phenotype, which make up about 5% of thoracic duct lymphocytes, were found to provide help for secondary antibody responses and produce interleukin 2 (IL-2) and IL-4, but no interferon gamma, on in vitro activation. These data provide evidence for the presence of autoreactive T cells in the normal immune system of the rat and reveal that in the intact animal these cells are prevented from expressing their autoreactive potential by other T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., & Locksley, R. M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.59 · Cited by 1,454
The route of re-circulation of lymphocytes in the rat
Gowans, J. L., & Knight, E. J. (1964) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1964.0001 · Cited by 1,453
Human TH1 and TH2 subsets: doubt no more
Romagnani, S. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90120-i · Cited by 1,089
Williams, A. F., Galfrè, G., & Milstein, C. (1977) · Cell · doi:10.1016/0092-8674(77)90266-5 · Cited by 764
Identification of Ia glycoproteins in rat thymus and purification from rat spleen
McMaster, W. R., & Williams, A. F. (1979) · European Journal of Immunology · doi:10.1002/eji.1830090603 · Cited by 678
Two subsets of rat T lymphocytes defined with monoclonal antibodies
Brideau, R. J., Carter, P. B., McMaster, W. R., Mason, D. W., & Williams, A. F. (1980) · European Journal of Immunology · doi:10.1002/eji.1830100807 · Cited by 667
Self-citationSadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S., & Locksley, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.115 · Cited by 620
Bendelac, A., Carnaud, C., Boitard, C., & Bach, J. F. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.823 · Cited by 569
Cited by
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Read, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Sakaguchi, S. (2000) · Cell · doi:10.1016/s0092-8674(00)80856-9 · Cited by 1,815
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., & Nomura, T. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00427.x · Cited by 1,555
Cytokines Induce the Development of Functionally Heterogeneous T Helper Cell Subsets
O'Garra, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80533-6 · Cited by 1,533
Regulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific
Thornton, A. M., & Shevach, E. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.183 · Cited by 1,229
Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5317 · Cited by 1,211
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
Insulin-Dependent Diabetes Mellitus
Tisch, R., & McDevitt, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81106-x · Cited by 1,150
Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
Liblau, R. S., Singer, S. M., & McDevitt, H. O. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80068-9 · Cited by 1,105
Powrie, F., Carlino, J., Leach, M. W., Mauze, S., & Coffman, R. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2669 · Cited by 894
IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo
Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J., Powrie, F., & Wood, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3789 · Cited by 766
Kingsley, C. I., Karim, M., Bushell, A. R., & Wood, K. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1080 · Cited by 743
Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells
Piccirillo, C. A., & Shevach, E. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1137 · Cited by 716
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Following a diabetogenic T cell from genesis through pathogenesis
Katz, J. D., Wang, B., Haskins, K., Benoist, C., & Mathis, D. (1993) · Cell · doi:10.1016/0092-8674(93)90730-e · Cited by 696
Autoimmune Thyroid Disease: Further Developments in Our Understanding*
WEETMAN, A. P., & McGREGOR, A. M. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-6-788 · Cited by 658
Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells
Gilliet, M., & Liu, Y.-J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011603 · Cited by 638
Powrie, F., Correa-Oliveira, R., Mauze, S., & Coffman, R. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.589 · Cited by 613
Rapoport, M. J., Jaramillo, A., Zipris, D., Lazarus, A. H., Serreze, D. V., Leiter, E. H., Cyopick, P., Danska, J. S., & Delovitch, T. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.87 · Cited by 507
Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activityin vitro
Stephens, L. A., Mottet, C., Mason, D., & Powrie, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1247::aid-immu1247>3.0.co;2-m · Cited by 486
Self-citationRabinovitch, A., & Suarez-Pinzon, W. L. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00492-9 · Cited by 466
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis
Coles, A. J., Wing, M., Smith, S., Coraddu, F., Greer, S., Taylor, C., Weetman, A., Hale, G., Chatterjee, V. K., Waldmann, H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02429-0 · Cited by 453
Fehérvari, Z., & Sakaguchi, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423395 · Cited by 452
Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.
Goodnow, C. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2264 · Cited by 446
Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.
Murphy, E., Shibuya, K., Hosken, N., Openshaw, P., Maino, V, Davis, K., Murphy, K., & O'Garra, A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.901 · Cited by 435
Flügel, A., Berkowicz, T., Ritter, T., Labeur, M., Jenne, D. E., Li, Z., Ellwart, J. W., Willem, M., Lassmann, H., & Wekerle, H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00143-1 · Cited by 431
Regulatory T cells under scrutiny
François Bach, J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1026 · Cited by 413
Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target
Sojka, D. K., Huang, Y., & Fowell, D. J. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02813.x · Cited by 393
Self-citationA two-step, two-signal model for the primary activation of precursor helper T cells
Bretscher, P. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.185 · Cited by 386
Regulatory T cells – a brief history and perspective
Sakaguchi, S., Wing, K., & Miyara, M. (2007) · European Journal of Immunology · doi:10.1002/eji.200737593 · Cited by 362
Both CD4+CD25+ and CD4+CD25− Regulatory Cells Mediate Dominant Transplantation Tolerance
Graca, L., Thompson, S., Lin, C.-Y., Adams, E., Cobbold, S. P., & Waldmann, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5558 · Cited by 362
T cells in inflammatory bowel disease: protective and pathogenic roles
Powrie, F. (1995) · Immunity · doi:10.1016/1074-7613(95)90086-1 · Cited by 351
Self-representation in the thymus: an extended view
Kyewski, B., & Derbinski, J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1436 · Cited by 342
A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
Scott, B., Liblau, R., Degermann, S., Marconi, L. A., Ogata, L., Caton, A. J., McDevitt, H. O., & Lo, D. (1994) · Immunity · doi:10.1016/1074-7613(94)90011-6 · Cited by 338
Self-Tolerance Checkpoints in B Lymphocyte Development
(1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60633-1 · Cited by 328
Stephens, L. A., & Mason, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3105 · Cited by 311
Self-citationPancreatic Lymph Node-Derived CD4+CD25+ Treg Cells
Green, E. A., Choi, Y., & Flavell, R. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00279-0 · Cited by 310
“…lesser extent, CD4 T cells (Green et al., 2000; Oxenius et al., 1996; Whitmire et al., 1996). suppress various autoimmune diseases, including diabetes (Fowell and Mason, 1993; Gershon and Kondo,Thus, in inflammation-based models of autoimmunity CD4 T cell help for APC and CD8 T cell activation is…”
BackgroundOlivares-Villagómez, D., Wang, Y., & Lafaille, J. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1883 · Cited by 294
Kuniyasu, Y., Takahashi, T., Itoh, M., Shimizu, J., Toda, G., & Sakaguchi, S. (2000) · International Immunology · doi:10.1093/intimm/12.8.1145 · Cited by 290
Control of Autoimmunity by Naturally Arising Regulatory CD4+ T Cells
(2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81008-8 · Cited by 283
Dendritic Cells in Transplantation—Friend or Foe?
Lechler, R., Ng, W. F., & Steinman, R. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00116-9 · Cited by 279
Control of immune pathology by regulatory T cells
Mason, D., & Powrie, F. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80084-8 · Cited by 278
Self-citationThe Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases
Prud'homme, G. J., & Piccirillo, C. A. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0339 · Cited by 276
Peripheral Autoantigen Induces Regulatory T Cells that Prevent Autoimmunity
Seddon, B., & Mason, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.877 · Cited by 274
Self-citationThe pathogenesis of immune thrombocytopaenic purpura
Cooper, N., & Bussel, J. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06024.x · Cited by 272
IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease
Röcken, M., Racke, M., & Shevach, E. M. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80556-1 · Cited by 264
The role of IL-12 in the induction of organ-specific autoimmune diseases
Trembleau, S., Adorini, L., Germann, T., & Gately, M. K. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80006-9 · Cited by 263
Seddon, B., & Mason, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.279 · Cited by 255
Self-citationCentral CD4+ T cell tolerance: deletion versus regulatory T cell differentiation
Klein, L., Robey, E. A., & Hsieh, C.-S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0083-6 · Cited by 214
Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist
Lin, C., & Hünig, T. (2003) · European Journal of Immunology · doi:10.1002/eji.200323570 · Cited by 184
(2007) · PubMed · Cited by 100
Skapenko, A., Lipsky, P. E., Kraetsch, H.-G., Kalden, J. R., & Schulze-Koops, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4283 · Cited by 42
“Resolution of inflammation in these diseases, by contrast, was associated with differentiation of Th2 cells (8, 9).”
BackgroundTerrada, C., Fisson, S., De Kozak, Y., Kaddouri, M., Lehoang, P., Klatzmann, D., Salomon, B. L., & Bodaghi, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7171 · Cited by 38
Metadata
- Authors
- Fowell, D., & Mason, D.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-03-01
- Volume
- 177
- Issue
- 3
- Pages
- 627-636
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2160306941
- Cited by
- 436
- References
- 54
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.